Sartorius AG Concludes Annual General Meeting with Key Resolutions

On March 26, 2026, Sartorius AG, headquartered in Göttingen, Germany, convened its Annual General Meeting. Shareholders overwhelmingly approved all the Supervisory and Executive Boards' proposals. Among the resolutions was the approval of dividends amounting to 0.74 euros per preference share and 0.73 euros per ordinary share. In total, 50.8 million euros will be disbursed to shareholders, with the payout scheduled for March 31, 2026.

Sartorius AG is noted for its strong international presence in the biopharmaceutical research and manufacturing sectors. With about 60 production and sales locations globally, the company continues to expand its portfolio through strategic acquisitions. In 2025, Sartorius achieved a sales revenue of approximately 3.5 billion euros, supported by its workforce of over 14,000 employees worldwide.